Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03353610 · ClinicalTrials.gov registry record
The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.
A clinical trial, sponsored by Milestone Pharmaceuticals.
- Terminated
- Registry status
- 354
- Enrollment target
NCT03353610: Clinical Trial study, sponsored by Milestone Pharmaceuticals.
NCT03353610 is a clinical trial that was terminated before completion, run by Milestone Pharmaceuticals. The registered enrollment target is 354 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03353610 was terminated before completion, sponsored by Milestone Pharmaceuticals.
- TERMINATED
- Registry status
- 354 participants
- Enrollment target
Study Summary
Paroxysmal supraventricular tachycardia (PSVT) is a sporadic, sudden, and recurring tachycardia that is caused by an altered electrical conductivity in the heart. It causes palpitations and a rapid heart rate, which may induce fear in the patient and negatively impact the patient's quality of life. Therefore, most patients experience not only physical symptoms of PSVT, but also dramatic psychological burdens. As PSVT drug development efforts advance, it has become increasingly important to document the impact of PSVT in a systematic way, in terms of the disease natural history and clinical characteristics of PSVT episodes, as well as the psychological impact of the condition as reported by patients over time. In order to meet the needs for ongoing, systematic data collection on PSVT, a multinational registry, The PSVT Place Registry (www.PSVTPlaceRegistry.com), is being implemented and will be initially comprised of data entered directly by patients. The long-term registry is designed with a participant-focused approach to enable continuity of data collection and minimization of impact from changes of participants' health care providers. The registry may be expanded at a later time to include physician-reported data. The information from the registry is planned to be a resource for participants with PSVT, their families and support networks, their doctors, and the research community to better understand PSVT-related symptoms and awareness, PSVT diagnoses, patient self-management, medical treatments for PSVT, and impact of PSVT on quality of life from the patient perspective.
Primary Outcome
The patient is able to report the frequency (number of PSVT episodes per day, week, month, etc.) for each of their recurring PSVT episodes. Changes in PSVT episode frequency over time will also be assessed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 2017-10-16 |
| Est. Completion | 2020-03-16 |
Why NCT03353610 stopped before completion
NCT03353610 is an observational study that tracks outcomes without assigning an intervention. The registered 354 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03353610 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03353610 about?
NCT03353610 is a clinical study titled "The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.". Paroxysmal supraventricular tachycardia (PSVT) is a sporadic, sudden, and recurring tachycardia that is caused by an altered electrical conductivity in the heart. It causes palpitations and a rapid heart rate, which may induce fear in the patient and negatively impact the patient's quality of life. ...
What is the current status of trial NCT03353610?
This trial is currently terminated. The enrollment target is 354 participants. The study started on 2017-10-16. Estimated completion is 2020-03-16.
Who is sponsoring clinical trial NCT03353610?
This trial is sponsored by Milestone Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02579967 · 354 participants · Phase 2
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- NCT02610413 · 354 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
- NCT05729256 · 354 participants · NA
Alcohol and "Heat of the Moment" Sexual Decision Making
- NCT06507618 · 354 participants · Phase 3
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI